| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $4.5B | $4.2B | $3.8B | $2.8B | $1.8B | $1.1B | $0.7B |
| Cost of Revenue | $2.6B | $2.2B | $2.1B | $2.0B | $1.5B | $0.8B | $0.5B | $0.3B |
| Gross Profit | $2.5B | $2.3B | $2.0B | $1.8B | $1.4B | $0.9B | $0.6B | $0.3B |
| R&D Expense | $1.0B | $1.0B | $0.9B | $1.1B | $0.8B | $0.5B | $0.4B | $0.2B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $-0.1B | $-0.9B | $-1.2B | $-0.9B | $-0.5B | $-0.4B | $-0.1B |
| Net Income | $0.0B | $-0.1B | $-1.0B | $-1.3B | $-0.9B | $-0.5B | $-0.3B | $-0.1B |
| EPS (Basic) | $0.22 | $-0.66 | $-5.54 | $-6.86 | $-5.45 | — | — | — |
| EPS (Diluted) | $0.21 | $-0.66 | $-5.54 | $-6.86 | $-5.45 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.8B | $9.9B | $11.6B | $12.6B | $13.0B | $9.5B | $5.2B | $1.0B |
| Current Assets | $3.6B | $3.4B | $4.9B | $5.0B | $5.9B | $3.4B | $2.1B | $0.9B |
| Cash & Equivalents | $0.7B | $0.4B | $0.7B | $0.7B | $1.5B | $0.9B | $0.3B | $0.5B |
| Total Liabilities | $1.9B | $1.9B | $1.9B | $2.0B | $2.0B | $1.0B | $0.9B | $0.6B |
| Current Liabilities | $0.9B | $0.8B | $0.7B | $0.8B | $0.7B | $0.4B | $0.2B | $0.1B |
| Stockholders' Equity | $7.8B | $8.0B | $9.7B | $10.6B | $11.0B | $8.5B | $4.3B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.7B | $0.4B | $-0.3B | $-0.1B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $0.1B | $1.4B | $0.2B | $-0.6B | $-2.5B | $-0.8B | $-1.3B | $-0.1B |
| Capital Expenditures | — | — | — | — | $0.0B | $0.0B | — | $0.0B |
| Financing Cash Flow | $-0.8B | $-2.3B | $-0.6B | $0.0B | $3.1B | $1.5B | $1.0B | $0.5B |